430 related articles for article (PubMed ID: 23183941)
1. Effect of statins on skeletal muscle function.
Parker BA; Capizzi JA; Grimaldi AS; Clarkson PM; Cole SM; Keadle J; Chipkin S; Pescatello LS; Simpson K; White CM; Thompson PD
Circulation; 2013 Jan; 127(1):96-103. PubMed ID: 23183941
[TBL] [Abstract][Full Text] [Related]
2. Increases in creatine kinase with atorvastatin treatment are not associated with decreases in muscular performance.
Ballard KD; Parker BA; Capizzi JA; Grimaldi AS; Clarkson PM; Cole SM; Keadle J; Chipkin S; Pescatello LS; Simpson K; White CM; Thompson PD
Atherosclerosis; 2013 Sep; 230(1):121-4. PubMed ID: 23958263
[TBL] [Abstract][Full Text] [Related]
3. A randomized clinical trial to assess the effect of statins on skeletal muscle function and performance: rationale and study design.
Thompson PD; Parker BA; Clarkson PM; Pescatello LS; White CM; Grimaldi AS; Levine BD; Haller RG; Hoffman EP
Prev Cardiol; 2010; 13(3):104-11. PubMed ID: 20626664
[TBL] [Abstract][Full Text] [Related]
4. The creatine kinase response to eccentric exercise with atorvastatin 10 mg or 80 mg.
Kearns AK; Bilbie CL; Clarkson PM; White CM; Sewright KA; O'Fallon KS; Gadarla M; Thompson PD
Atherosclerosis; 2008 Sep; 200(1):121-5. PubMed ID: 18261731
[TBL] [Abstract][Full Text] [Related]
5. The effect of statins on skeletal muscle function: the STOMP trial.
Farmer JA
Curr Atheroscler Rep; 2013 Aug; 15(8):347. PubMed ID: 23843151
[No Abstract] [Full Text] [Related]
6. Statin-associated myopathy with normal creatine kinase levels.
Phillips PS; Haas RH; Bannykh S; Hathaway S; Gray NL; Kimura BJ; Vladutiu GD; England JD;
Ann Intern Med; 2002 Oct; 137(7):581-5. PubMed ID: 12353945
[TBL] [Abstract][Full Text] [Related]
7. Effect of atorvastatin on energy expenditure and skeletal muscle oxidative metabolism at rest and during exercise.
Chung J; Brass EP; Ulrich RG; Hiatt WR
Clin Pharmacol Ther; 2008 Feb; 83(2):243-50. PubMed ID: 17554242
[TBL] [Abstract][Full Text] [Related]
8. Comparative safety of atorvastatin 80 mg versus 10 mg derived from analysis of 49 completed trials in 14,236 patients.
Newman C; Tsai J; Szarek M; Luo D; Gibson E
Am J Cardiol; 2006 Jan; 97(1):61-7. PubMed ID: 16377285
[TBL] [Abstract][Full Text] [Related]
9. Changes in ubiquitin proteasome pathway gene expression in skeletal muscle with exercise and statins.
Urso ML; Clarkson PM; Hittel D; Hoffman EP; Thompson PD
Arterioscler Thromb Vasc Biol; 2005 Dec; 25(12):2560-6. PubMed ID: 16224050
[TBL] [Abstract][Full Text] [Related]
10. Safety of atorvastatin derived from analysis of 44 completed trials in 9,416 patients.
Newman CB; Palmer G; Silbershatz H; Szarek M
Am J Cardiol; 2003 Sep; 92(6):670-6. PubMed ID: 12972104
[TBL] [Abstract][Full Text] [Related]
11. STOMPing forward: statins, muscle complaints and CK.
Laaksonen R
Atherosclerosis; 2013 Oct; 230(2):256-7. PubMed ID: 24075753
[No Abstract] [Full Text] [Related]
12. Atorvastatin metabolite measurements as a diagnostic tool for statin-induced myopathy.
Skottheim IB; Bogsrud MP; Hermann M; Retterstøl K; Åsberg A
Mol Diagn Ther; 2011 Aug; 15(4):221-7. PubMed ID: 21815705
[TBL] [Abstract][Full Text] [Related]
13. Discontinuation of statin therapy due to muscular side effects: a survey in real life.
Rosenbaum D; Dallongeville J; Sabouret P; Bruckert E
Nutr Metab Cardiovasc Dis; 2013 Sep; 23(9):871-5. PubMed ID: 22748604
[TBL] [Abstract][Full Text] [Related]
14. Atorvastatin increases exercise leg blood flow in healthy adults.
Parker BA; Capizzi JA; Augeri AL; Grimaldi AS; Michael White C; Thompson PD
Atherosclerosis; 2011 Dec; 219(2):768-73. PubMed ID: 22018642
[TBL] [Abstract][Full Text] [Related]
15. [Rhabdomyolysis following the coprescription of atorvastatin and fusidic acid].
Gabignon C; Zeller V; Le Guyader N; Desplaces N; Lidove O; Ziza JM
Rev Med Interne; 2013 Jan; 34(1):39-41. PubMed ID: 23102978
[TBL] [Abstract][Full Text] [Related]
16. No adverse effects of statins on muscle function and health-related parameters in the elderly: an exercise study.
Panayiotou G; Paschalis V; Nikolaidis MG; Theodorou AA; Deli CK; Fotopoulou N; Fatouros IG; Koutedakis Y; Sampanis M; Jamurtas AZ
Scand J Med Sci Sports; 2013 Oct; 23(5):556-67. PubMed ID: 22288788
[TBL] [Abstract][Full Text] [Related]
17. Randomized trial of atorvastatin for reduction of myocardial damage during coronary intervention: results from the ARMYDA (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) study.
Pasceri V; Patti G; Nusca A; Pristipino C; Richichi G; Di Sciascio G;
Circulation; 2004 Aug; 110(6):674-8. PubMed ID: 15277322
[TBL] [Abstract][Full Text] [Related]
18. Muscle symptoms associated with statins: a series of twenty patients.
Soininen K; Niemi M; Kilkki E; Strandberg T; Kivistö KT
Basic Clin Pharmacol Toxicol; 2006 Jan; 98(1):51-4. PubMed ID: 16433891
[TBL] [Abstract][Full Text] [Related]
19. Open-label tofacitinib and double-blind atorvastatin in rheumatoid arthritis patients: a randomised study.
McInnes IB; Kim HY; Lee SH; Mandel D; Song YW; Connell CA; Luo Z; Brosnan MJ; Zuckerman A; Zwillich SH; Bradley JD
Ann Rheum Dis; 2014 Jan; 73(1):124-31. PubMed ID: 23482473
[TBL] [Abstract][Full Text] [Related]
20. Effects of atorvastatin on bone in postmenopausal women with dyslipidemia: a double-blind, placebo-controlled, dose-ranging trial.
Bone HG; Kiel DP; Lindsay RS; Lewiecki EM; Bolognese MA; Leary ET; Lowe W; McClung MR
J Clin Endocrinol Metab; 2007 Dec; 92(12):4671-7. PubMed ID: 17726081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
